Biotage AB (BIOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biotage AB (BIOT) has a cash flow conversion efficiency ratio of 0.011x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr43.00 Million ≈ $4.63 Million USD) by net assets (Skr3.85 Billion ≈ $413.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Biotage AB worth for the company's overall valuation and market capitalisation.
Biotage AB - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Biotage AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Biotage AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biotage AB ranked by their cash flow conversion efficiency. Explore BIOT cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Herbalife Nutrition Ltd
NYSE:HLF
|
-0.193x |
|
Treehouse Foods Inc
NYSE:THS
|
0.030x |
|
Xiamen Solex High-Tech Industries Co Ltd
SHG:603992
|
0.021x |
|
OCI Co Ltd
KO:010060
|
-0.014x |
|
Hoymiles Power Electronics Inc
SHG:688032
|
-0.037x |
|
Grupo Televisa S.A.B.
F:TLV
|
0.100x |
|
Beijing Urban Construction Investment & Development Co Ltd
SHG:600266
|
0.032x |
|
Koh Young Technology Inc
KQ:098460
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Biotage AB (2002–2024)
The table below shows the annual cash flow conversion efficiency of Biotage AB from 2002 to 2024. View BIOT stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr4.11 Billion ≈ $442.62 Million |
Skr413.00 Million ≈ $44.45 Million |
0.100x | +29.30% |
| 2023-12-31 | Skr3.66 Billion ≈ $393.55 Million |
Skr284.00 Million ≈ $30.56 Million |
0.078x | -62.72% |
| 2022-12-31 | Skr1.64 Billion ≈ $176.17 Million |
Skr341.00 Million ≈ $36.70 Million |
0.208x | -19.04% |
| 2021-12-31 | Skr1.37 Billion ≈ $147.65 Million |
Skr353.00 Million ≈ $37.99 Million |
0.257x | -8.72% |
| 2020-12-31 | Skr990.04 Million ≈ $106.54 Million |
Skr279.05 Million ≈ $30.03 Million |
0.282x | +16.50% |
| 2019-12-31 | Skr875.50 Million ≈ $94.22 Million |
Skr211.81 Million ≈ $22.79 Million |
0.242x | +9.59% |
| 2018-12-31 | Skr702.18 Million ≈ $75.57 Million |
Skr155.00 Million ≈ $16.68 Million |
0.221x | -20.47% |
| 2017-12-31 | Skr608.61 Million ≈ $65.50 Million |
Skr168.93 Million ≈ $18.18 Million |
0.278x | +12.42% |
| 2016-12-31 | Skr563.24 Million ≈ $60.61 Million |
Skr139.07 Million ≈ $14.97 Million |
0.247x | +12.41% |
| 2015-12-31 | Skr546.66 Million ≈ $58.83 Million |
Skr120.08 Million ≈ $12.92 Million |
0.220x | +36.47% |
| 2014-12-31 | Skr502.65 Million ≈ $54.09 Million |
Skr80.91 Million ≈ $8.71 Million |
0.161x | +35.21% |
| 2013-12-31 | Skr476.77 Million ≈ $51.31 Million |
Skr56.76 Million ≈ $6.11 Million |
0.119x | -15.15% |
| 2012-12-31 | Skr530.83 Million ≈ $57.13 Million |
Skr74.47 Million ≈ $8.01 Million |
0.140x | -27.45% |
| 2011-12-31 | Skr563.90 Million ≈ $60.68 Million |
Skr109.05 Million ≈ $11.74 Million |
0.193x | +90.70% |
| 2010-12-31 | Skr567.95 Million ≈ $61.12 Million |
Skr57.59 Million ≈ $6.20 Million |
0.101x | +204.67% |
| 2009-12-31 | Skr1.09 Billion ≈ $117.20 Million |
Skr36.25 Million ≈ $3.90 Million |
0.033x | -57.81% |
| 2008-12-31 | Skr1.12 Billion ≈ $121.05 Million |
Skr88.74 Million ≈ $9.55 Million |
0.079x | +86.31% |
| 2007-12-31 | Skr796.26 Million ≈ $85.69 Million |
Skr33.72 Million ≈ $3.63 Million |
0.042x | -24.40% |
| 2006-12-31 | Skr712.47 Million ≈ $76.67 Million |
Skr39.91 Million ≈ $4.29 Million |
0.056x | +303.79% |
| 2005-12-31 | Skr738.25 Million ≈ $79.45 Million |
Skr-20.29 Million ≈ $-2.18 Million |
-0.027x | +85.31% |
| 2004-12-31 | Skr523.13 Million ≈ $56.30 Million |
Skr-97.89 Million ≈ $-10.53 Million |
-0.187x | -13.75% |
| 2003-12-31 | Skr609.50 Million ≈ $65.59 Million |
Skr-100.27 Million ≈ $-10.79 Million |
-0.165x | +20.20% |
| 2002-12-31 | Skr616.16 Million ≈ $66.31 Million |
Skr-127.02 Million ≈ $-13.67 Million |
-0.206x | -- |
About Biotage AB
Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation produ… Read more